Natasha Appelman-Dijkstra
1 clinical trials · Sponsor
◉ Watch Natasha Appelman-Dijkstra
| Record | Firm | Date |
|---|---|---|
| DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) (NCT05966064) | Natasha Appelman-Dijkstra | 2023-06-13 |
Track Natasha Appelman-Dijkstra automatically
Every clearance here is in the API, with alerts when new ones post.